July 2019
Volume 60, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2019
QUALITY OF LIFE AND PSYCHOSOCIAL ASPECTS IN PATIENTS WITH OCULAR TOXOPLASMOSIS: a clinical study in a tertiary care hospital in Brazil
Author Affiliations & Notes
  • Aristofanes Canamary Jr
    Visual Science, Federal University of São Paulo, Sao Paulo, Sao Paulo, Brazil
  • Cristina Muccioli
    Visual Science, Federal University of São Paulo, Sao Paulo, Sao Paulo, Brazil
  • Luci Silva
    Visual Science, Federal University of São Paulo, Sao Paulo, Sao Paulo, Brazil
  • Monique Mangeon
    Visual Science, Federal University of São Paulo, Sao Paulo, Sao Paulo, Brazil
  • Isabela Ribeiro
    Visual Science, Federal University of São Paulo, Sao Paulo, Sao Paulo, Brazil
  • Footnotes
    Commercial Relationships   Aristofanes Canamary Jr, None; Cristina Muccioli, None; Luci Silva, None; Monique Mangeon, None; Isabela Ribeiro, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 4472. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Aristofanes Canamary Jr, Cristina Muccioli, Luci Silva, Monique Mangeon, Isabela Ribeiro; QUALITY OF LIFE AND PSYCHOSOCIAL ASPECTS IN PATIENTS WITH OCULAR TOXOPLASMOSIS: a clinical study in a tertiary care hospital in Brazil. Invest. Ophthalmol. Vis. Sci. 2019;60(9):4472.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Evaluate the quality of life in patients with uveitis related to toxoplasmosis and its correlation with demographic, ocular involvement and psychosocial aspects. This was a cross-sectional observational study.

Methods : 81 subjects were recruited with a mean age of 41,5 ± 14.5 years old, most were female (n=41; 50,6%).
Inclusion criteria were patients 18 yo and older, with clinical diagnosis of ocular toxoplasmosis and ability to respond to the study interview and provide informed consent. A comprehensive ophthalmic exam was performed with measurement of best-corrected visual acuity.
Three validated and standardized questionnaires Hospital Anxiety and Depression Scale (HADS); Short – Form Health Survey (SF-12); National Eye Institute Visual Function Questionnaire (NEI - VFQ-25); and a questionnaire structured by the researchers, to collect demographic and ocular involvement data were used. Statistical analysis used were Kruskal–Wallis and Mann–Whitney test. Data were entered and stored in the spreadsheet Microsoft Office Excel 2003 and were statistically analyzed using Statistica software version 5.1/97 for Mann–Whitney, Kruskal–Wallis and Spearman’ s correlation test.

Results : HADS scale showed a mean score of 5.9 ± 4.1 for anxiety and 38% of subjects had symptoms of anxiety ranked from mild to severe. Symptoms of anxiety were significantly associated with visual status category (p = 0.037). The mean of SF-12 physical and mental components scores were 48.5 ± 7.4 and 52.4 ± 10.6 and the mean of VFQ-25 score was 75.3 ± 19.5.
Through univariate analyses, on SF-12, comparing demographic and ocular features, associations were found with statistical significance in domains such as role physical (p=0,017), role emotional (p=0,016) and mental component summary (p=0,019) for visual acuity category.
On VFQ-25 associations were found with statistical significance in all domains for exception general health, general vision and color vision for visual acuity category. Significance were found for female gender in General health (p= 0,011); bilateral involvement for near activities (p= 0,016), distance activities (p= 0,017) and global component score (p= 0,049).

Conclusions : Visual impairment secondary to ocular toxoplasmosis has impact on several scales of health related quality of life. Also affects psychological aspects beeing anxiety symptoms more common.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×